Episode 79
Host Aaron Lohr talks with Irl Hirsch from the University of Washington, co-chair of the Endocrine Society’s type 1 diabetes fellows program, about the program and the latest in type 1 diabetes research and treatment, as well as forecast for future technology and treatment opportunities. The fellows program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
